{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:16Z","timestamp":1792611676511,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.contraception.2025.110978","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:29:40Z","timestamp":1748597380000},"page":"110978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Progestin-only contraception and thrombosis: An updated systematic review"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-6382","authenticated-orcid":false,"given":"Naomi K.","family":"Tepper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.110978_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jwh.2015.5259","article-title":"Risk factors for venous thromboembolism among reproductive age women","volume":"25","author":"Westhoff","year":"2016","journal-title":"J Womens Health"},{"key":"10.1016\/j.contraception.2025.110978_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082801","article-title":"Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study","volume":"388","author":"Yonis","year":"2025","journal-title":"Brit Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5853\/jos.2022.03468","article-title":"Stroke in women: a review focused on epidemiology, risk factors, and outcomes","volume":"25","author":"Yoon","year":"2023","journal-title":"J Stroke"},{"key":"10.1016\/j.contraception.2025.110978_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib5","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.110978_bib6","first-page":"CD011054","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.110978_bib7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.contraception.2025.110978_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1365-2141.2010.08206.x","article-title":"Risk factors for venous thrombosis - current understanding from an epidemiological point of view","volume":"149","author":"Lijfering","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2025.110978_bib10","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.contraception.2025.110978_bib11","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.110978_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/VHRM.S404537","article-title":"Venous thromboembolism in pregnancy: challenges and solutions","volume":"19","author":"Varrias","year":"2023","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.contraception.2025.110978_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.110978_bib14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib15","unstructured":"Veritas Health Innovation. Covidence systematic review software. https:\/\/www.covidence.org\/\u00a0(accessed March 13, 2025)."},{"key":"10.1016\/j.contraception.2025.110978_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2025.110978_bib17","unstructured":"GRADEpro Guideline Development Tool [Software]. Hamilton, ON: McMaster University (developed by Evidence Prime); 2022. https:\/\/www.gradepro.org\/ (accessed March 13, 2025)."},{"key":"10.1016\/j.contraception.2025.110978_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.110978_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110978_bib21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/AOG.0000000000003760","article-title":"Association of immediate postpartum etonogestrel implant insertion and venous thromboembolism","volume":"135","author":"Floyd","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110978_bib22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"Heikinheimo","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2025.110978_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jadohealth.2022.02.009","article-title":"Management of contraception in adolescent females with hormone-related venous thromboembolism","volume":"71","author":"Maher","year":"2022","journal-title":"J Adolescent Health"},{"key":"10.1016\/j.contraception.2025.110978_bib24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.110978_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/dc16-1534","article-title":"Hormonal contraception and risk of thromboembolism in women with diabetes","volume":"40","author":"O'Brien","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.contraception.2025.110978_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/AOG.0000000000003135","article-title":"Venous thromboembolism among women initiating depot medroxyprogesterone acetate immediately postpartum","volume":"133","author":"Tepper","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110978_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2025.110978_bib29","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.thromres.2012.05.024","article-title":"Risk factors for venous thromboembolism in pre- and postmenopausal women","volume":"130","author":"Bergendal","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2025.110978_bib30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","article-title":"Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes","volume":"124","author":"Bergendal","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110978_bib31","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1538-7836.2010.03994.x","article-title":"Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event","volume":"8","author":"Christiansen","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110978_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.contraception.2004.07.009","article-title":"Progestogen-only contraception in women at high risk of venous thromboembolism","volume":"70","author":"Conard","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib33","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","article-title":"Oral contraceptives and myocardial infarction: results of the MICA case-control study","volume":"318","author":"Dunn","year":"1999","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13625189909064007","article-title":"Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"4","author":"Heinemann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.110978_bib35","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.3324\/haematol.2015.134882","article-title":"Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study","volume":"101","author":"Le Moigne","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.contraception.2025.110978_bib36","first-page":"956","article-title":"Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study","volume":"306","author":"Lidegaard","year":"1993","journal-title":"Br\u00a0Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0010-7824(98)00033-X","article-title":"Oral contraceptives and venous thromboembolism. A case-control study","volume":"57","author":"Lidegaard","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","article-title":"Contraceptives and cerebral thrombosis: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib40","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.contraception.2025.110978_bib41","first-page":"b2890","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"Br\u00a0Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib42","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"Br\u00a0Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib43","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-7824(84)90076-3","article-title":"Contraception with progestagens in systemic lupus erythematosus","volume":"30","author":"Mintz","year":"1984","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(98)00036-5","article-title":"Norplant implants and cardiovascular disease","volume":"57","author":"Petitti","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib46","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2025.110978_bib47","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archinte.161.8.1065","article-title":"Low-dose oral contraceptive use and the risk of myocardial infarction","volume":"161","author":"Rosenberg","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2025.110978_bib48","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1471-0528.1991.tb15397.x","article-title":"Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study","volume":"98","author":"Thorogood","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2025.110978_bib49","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bmj.310.6983.830","article-title":"Case-control study of migraine and risk of ischaemic stroke in young women","volume":"310","author":"Tzourio","year":"1995","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib50","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.contraception.2011.06.008","article-title":"Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives","volume":"84","author":"Vaillant-Roussel","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.110978_bib51","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscl Throm Vas"},{"key":"10.1016\/j.contraception.2025.110978_bib52","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestagens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2025.110978_bib53","unstructured":"CDC. Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024;\u00a02024. https:\/\/stacks.cdc.gov\/view\/cdc\/156516\u00a0(accessed March 13, 2025)."},{"key":"10.1016\/j.contraception.2025.110978_bib54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/13625187.2021.1931839","article-title":"Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study","volume":"26","author":"Kurvits","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2025.110978_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/00016340902730375","article-title":"Limited knowledge on progestogen-only contraception and risk of venous thromboembolism","volume":"88","author":"Bergendal","year":"2009","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2025.110978_bib56","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.2010-2065","article-title":"Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis","volume":"96","author":"Chakhtoura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2025.110978_bib57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chakhtoura","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.contraception.2025.110978_bib58","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2025.110978_bib59","doi-asserted-by":"crossref","first-page":"e2444","DOI":"10.1212\/WNL.0000000000007533","article-title":"Stroke incidence in young adults according to age, subtype, sex, and time trends","volume":"92","author":"Ekker","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2025.110978_bib60","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/AOG.0b013e31820ce2db","article-title":"Risk of venous thromboembolism during the postpartum period: a systematic review","volume":"117","author":"Jackson","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.110978_bib61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH15-02-0141","article-title":"Classic thrombophilic gene variants","volume":"114","author":"Mannucci","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2025.110978_bib62","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1182\/blood-2009-05-220921","article-title":"Sickle cell disease and stroke","volume":"114","author":"Verduzco","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2025.110978_bib63","doi-asserted-by":"crossref","first-page":"H77","DOI":"10.1152\/ajpheart.00614.2020","article-title":"Influence of hormonal contraceptives on peripheral vascular function and structure in premenopausal females: a review","volume":"320","author":"Williams","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.contraception.2025.110978_bib64","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12978-023-01727-4","article-title":"Effects of hormonal contraceptives on lipid profile among women attending family planning unit in Goba Town Public Health Facilities, Bale, Southeast Ethiopia: a comparative cross-sectional study","volume":"20","author":"Turki","year":"2023","journal-title":"Reprod Health"},{"key":"10.1016\/j.contraception.2025.110978_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1447-0756.2000.tb01195.x","article-title":"Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A","volume":"26","author":"Diab","year":"2000","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.contraception.2025.110978_bib66","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jog.13306","article-title":"Effect of the injectable contraceptive depot-medroxyprogesterone acetate on coagulation parameters in new users","volume":"43","author":"Melhado-Kimura","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.contraception.2025.110978_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5122(96)00994-2","article-title":"Effects of progestogens on haemostasis","volume":"24","author":"Kuhl","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2025.110978_bib68","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.fertnstert.2006.11.040","article-title":"Effect of depomedroxyprogesterone acetate on coagulation parameter: a pilot study","volume":"87","author":"Goldstein","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2025.110978_bib69","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12905-020-01080-9","article-title":"Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24\/4 regime","volume":"20","author":"Palacios","year":"2020","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.contraception.2025.110978_bib70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2025.110978_bib71","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.thromres.2012.02.042","article-title":"Progestin-only contraception and venous thromboembolism","volume":"129","author":"Blanco-Molina","year":"2012","journal-title":"Thromb Res"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:17:49Z","timestamp":1780712269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":71,"alternative-id":["S0010782425001696"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110978","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestin-only contraception and thrombosis: An updated systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.110978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110978"}}